{
    "nct_id": "NCT03322462",
    "title": "A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD",
    "status": "COMPLETED",
    "last_update_time": "2020-08-07",
    "description_brief": "This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "DIAGNOSTIC",
    "results": {
        "participantFlowModule": {
            "recruitmentDetails": "Enrollment occurred between Nov 2017 and Aug 2018. Recruited subjects with clinically diagnosed early AD who were interested in participating in AD therapeutic clinical trial AACG (Eli Lilly and Company; TRAILBLAZER-ALZ; NCT03367403)",
            "groups": [
                {
                    "id": "FG000",
                    "title": "Early Symptomatic AD Subjects",
                    "description": "Early Symptomatic AD subjects in the flortaucipir PET scan arm"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "155"
                                }
                            ]
                        },
                        {
                            "type": "Flortaucipir PET Scan",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "155"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "152"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "3"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Technical difficulties",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Other",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Early Symptomatic AD Subjects",
                    "description": "Early Symptomatic AD subjects in the flortaucipir PET scan arm"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "155"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "74.7",
                                            "spread": "6.19"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "76"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "79"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "137"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "MMSE",
                    "description": "Mini-mental status exam (MMSE) is a 30-point questionnaire that is used to measure cognitive impairment. Scores range from 0 to 30 with lower scores representing greater levels of cognitive impairment.",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "24.5",
                                            "spread": "2.18"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Flortaucipir Qualitative Results (Visual Reads)",
                    "description": "Flortaucipir PET scans were rated visually by an expert reader as follows: Not consistent with an AD pattern (\u03c4AD-), Moderate AD pattern (\u03c4AD+), or Advanced AD pattern and likely to progress (\u03c4AD++). Eligibility for AACG study was determined from the flortaucipir PET scan quantitation (SUVr; see below) according to protocol-specified criteria that excluded subjects with tau PET signal that was above or below study criteria.",
                    "populationDescription": "Includes all subjects who completed the study with valid flortaucipir PET scan (n=152)",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "baseline scan",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Early Symptomatic AD, Eligible for AACG Study",
                            "description": "Subjects determined to be eligible for the AACG Study from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG001",
                            "title": "Early Symptomatic AD, Ineligible for AACG Study",
                            "description": "Subjects who were not eligible for the AACG Study from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG002",
                            "title": "Early Symptomatic AD (Total)",
                            "description": "All subjects with early symptomatic AD from the flortaucipir PET scan arm"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "58"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "94"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "152"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "\u03c4AD++, advanced AD pattern",
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "56"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "78"
                                        }
                                    ]
                                },
                                {
                                    "title": "\u03c4AD+, moderate AD pattern",
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "10"
                                        }
                                    ]
                                },
                                {
                                    "title": "\u03c4AD-, pattern not consistent with AD",
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "64"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "64"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Flortaucipir Quantitative Results (SUVr)",
                    "description": "Flortaucipir standardized uptake value ratio (SUVr). A value of 1 signifies no flortaucipir activity above background, values greater than 1 signify increasing flortaucipir activity in the brain. Visual read categories as described for previous measure. Eligibility for AACG study was determined from the flortaucipir PET scan quantitation (SUVr; see below) according to protocol-specified criteria that excluded subjects with tau PET signal that was above or below study criteria.",
                    "populationDescription": "SUVr was not collected for patients with a \u03c4AD- result",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "standardized uptake value ratio (SUVr)",
                    "timeFrame": "baseline scan",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Early Symptomatic AD, Eligible for AACG Study",
                            "description": "Subjects determined to be eligible for the AACG Study from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG001",
                            "title": "Early Symptomatic AD, Ineligible for AACG Study",
                            "description": "Subjects who were not eligible for the AACG Study from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG002",
                            "title": "Early Symptomatic AD (Total)",
                            "description": "All subjects with early symptomatic AD from the flortaucipir PET scan arm"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "58"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "30"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "88"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "SUVr all",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "58"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "88"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.21207",
                                            "spread": "0.119729"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.48576",
                                            "spread": "0.316435"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.30537",
                                            "spread": "0.244527"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SUVr \u03c4AD++ subjects",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "56"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "78"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.21518",
                                            "spread": "0.120696"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.65880",
                                            "spread": "0.143067"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.34031",
                                            "spread": "0.237395"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SUVr \u03c4AD+ subjects",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.12490",
                                            "spread": "0.012021"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.00991",
                                            "spread": "0.023239"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.03291",
                                            "spread": "0.052789"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "1",
            "timeFrame": "48 hours after study drug administration",
            "description": "Adverse events (AEs) were collected at scan visits, regardless of attribution to study drug. End of study for AE reporting was 48 hours after the last study drug administration. AEs occurring after study drug administration, but outside that window were not recorded, unless considered attributable to study drug.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Safety Analysis Population",
                    "description": "All subjects with early symptomatic AD from the flortaucipir PET scan arm who received one dose of flortaucipir",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 155,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 155,
                    "otherNumAffected": 2,
                    "otherNumAtRisk": 155
                }
            ],
            "otherEvents": [
                {
                    "term": "diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 21.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 155
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "LTE60",
                "restrictiveAgreement": true
            },
            "pointOfContact": {
                "title": "Medical Director",
                "organization": "Avid Radiopharmaceuticals, Inc.",
                "email": "clinicaloperations@avidrp.com",
                "phone": "215-298-0700"
            }
        }
    },
    "target_category": "N/A",
    "drug": [
        "flortaucipir F18 (TAUVID) \u2014 radioactive PET tracer for tau imaging (diagnostic agent, not a therapeutic drug)"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The protocol describes a pre-screening study using flortaucipir F18 PET (tau imaging) to determine eligibility for AD therapeutic trials. This intervention is a diagnostic radiopharmaceutical used to image aggregated tau (neurofibrillary tangles), not a treatment intended to modify disease, improve cognition, or treat neuropsychiatric symptoms. By the category definitions, trials that are purely diagnostic (imaging) should be classified as 'N/A'. \ue200cite\ue202turn0search0\ue202turn0search6\ue201",
        "Act: Key extracted details \u2014 flortaucipir F18 (brand name TAUVID) is an FDA\u2011approved radioactive diagnostic agent for PET imaging to estimate density and distribution of aggregated tau NFTs in patients being evaluated for Alzheimer\u2019s disease; it is supplied and used as an imaging tracer, not a therapeutic compound. Therefore the trial is diagnostic/pre\u2011screening rather than any of the four treatment categories. \ue200cite\ue202turn0search1\ue202turn0search0\ue201",
        "Reflect: Classification check \u2014 the trial's stated purpose (pre\u2011screening using flortaucipir F18 PET) matches the diagnostic use described in regulatory and manufacturer sources, so it does not fit \u2018disease\u2011targeted biologic\u2019, \u2018disease\u2011targeted small molecule\u2019, \u2018cognitive enhancer\u2019, or \u2018neuropsychiatric symptom improvement\u2019. Confirmed classification: 'N/A'. \ue200cite\ue202turn0search6\ue202turn0search3\ue201",
        "Web search results (supporting sources used): TAUVID product page (flortaucipir F18 PET tracer) \u2014 Eli Lilly. \ue200cite\ue202turn0search0\ue201; Lilly press release announcing FDA approval of TAUVID (May 28, 2020). \ue200cite\ue202turn0search1\ue201; FDA Drug Trial Snapshot for TAUVID (flortaucipir F18). \ue200cite\ue202turn0search6\ue201; Drugs.com summary of TAUVID approval and indication. \ue200cite\ue202turn0search2\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}